BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10404060)

  • 1. High frequency of inactivation of the imprinted H19 gene in "sporadic" hepatoblastoma.
    Fukuzawa R; Umezawa A; Ochi K; Urano F; Ikeda H; Hata J
    Int J Cancer; 1999 Aug; 82(4):490-7. PubMed ID: 10404060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma.
    Kim KS; Lee YI
    Cancer Lett; 1997 Nov; 119(2):143-8. PubMed ID: 9570364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
    Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
    Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma.
    Honda S; Arai Y; Haruta M; Sasaki F; Ohira M; Yamaoka H; Horie H; Nakagawara A; Hiyama E; Todo S; Kaneko Y
    Br J Cancer; 2008 Dec; 99(11):1891-9. PubMed ID: 19034281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of imprinting in hepatoblastoma.
    Rainier S; Dobry CJ; Feinberg AP
    Cancer Res; 1995 May; 55(9):1836-8. PubMed ID: 7728748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable imprinting of H19 and IGF2 in fetal cerebellum and medulloblastoma.
    Albrecht S; Waha A; Koch A; Kraus JA; Goodyer CG; Pietsch T
    J Neuropathol Exp Neurol; 1996 Dec; 55(12):1270-6. PubMed ID: 8957451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19.
    Hartmann W; Waha A; Koch A; Goodyer CG; Albrecht S; von Schweinitz D; Pietsch T
    Am J Pathol; 2000 Oct; 157(4):1393-403. PubMed ID: 11021841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multipoint analysis of human chromosome 11p15/mouse distal chromosome 7: inclusion of H19/IGF2 in the minimal WT2 region, gene specificity of H19 silencing in Wilms' tumorigenesis and methylation hyper-dependence of H19 imprinting.
    Dao D; Walsh CP; Yuan L; Gorelov D; Feng L; Hensle T; Nisen P; Yamashiro DJ; Bestor TH; Tycko B
    Hum Mol Genet; 1999 Jul; 8(7):1337-52. PubMed ID: 10369881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 11p15.5 regional imprinting: comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors.
    Chung WY; Yuan L; Feng L; Hensle T; Tycko B
    Hum Mol Genet; 1996 Aug; 5(8):1101-8. PubMed ID: 8842727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of H19, an imprinted and putative tumor repressor gene, is a preneoplastic event during Wilms' tumorigenesis.
    Cui H; Hedborg F; He L; Nordenskjöld A; Sandstedt B; Pfeifer-Ohlsson S; Ohlsson R
    Cancer Res; 1997 Oct; 57(20):4469-73. PubMed ID: 9377554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H19 and IGF-2 allele-specific expression in hepatoblastoma.
    Ross JA; Radloff GA; Davies SM
    Br J Cancer; 2000 Feb; 82(4):753-6. PubMed ID: 10732739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma.
    Anderson J; Gordon A; McManus A; Shipley J; Pritchard-Jones K
    Neoplasia; 1999 Oct; 1(4):340-8. PubMed ID: 10935489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression.
    Wilkin F; Gagné N; Paquette J; Oligny LL; Deal C
    J Clin Endocrinol Metab; 2000 May; 85(5):2048-56. PubMed ID: 10843195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic imprinting of IGF2 and H19 in human meningiomas.
    Müller S; Zirkel D; Westphal M; Zumkeller W
    Eur J Cancer; 2000 Mar; 36(5):651-5. PubMed ID: 10738131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imprinting of IGF2 and H19: lack of reciprocity in sporadic Beckwith-Wiedemann syndrome.
    Joyce JA; Lam WK; Catchpoole DJ; Jenks P; Reik W; Maher ER; Schofield PN
    Hum Mol Genet; 1997 Sep; 6(9):1543-8. PubMed ID: 9285792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.
    Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe JC; Stéhelin D; Coll J; Riou G
    Oncogene; 1996 Jan; 12(2):423-30. PubMed ID: 8570220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of normal imprinting of H19 and IGF2 genes in neuroblastoma.
    Wada M; Seeger RC; Mizoguchi H; Koeffler HP
    Cancer Res; 1995 Aug; 55(15):3386-8. PubMed ID: 7614476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Igf2 imprinting does not require its own DNA methylation or H19 RNA.
    Jones BK; Levorse JM; Tilghman SM
    Genes Dev; 1998 Jul; 12(14):2200-7. PubMed ID: 9679064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of imprinting and loss of heterozygosity on 11p15.5 in head and neck squamous cell carcinomas.
    Rainho CA; Kowalski LP; Rogatto SR
    Head Neck; 2001 Oct; 23(10):851-9. PubMed ID: 11592232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site.
    Cui H; Niemitz EL; Ravenel JD; Onyango P; Brandenburg SA; Lobanenkov VV; Feinberg AP
    Cancer Res; 2001 Jul; 61(13):4947-50. PubMed ID: 11431321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.